Prosigna Kits
The Royal Marsden NHS Foundation TrustcontractContracts Finder ↗Ref CF-0572500D0O000000rwimUAA1complete
Estimated value
£204k
Awarded value
£204k
Awarded 06 Jan 2022
Suppliers
1
Lots
1
1 awarded
Published
13 Jan 2022
Deadline 19 Dec 2021
Description
Breast cancer prognostic tests are genomic tests which are used to determine a woman's risk of hormone receptor breast cancer recurrence as well as how likely she is to benefit from chemotherapy after breast cancer surgery and/or extended endocrine treatm
Scope
- Reference
- CF-0572500D0O000000rwimUAA1
- Total value
- £204,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 20 Dec 2021 to 19 Dec 2023
- CPV classifications
- 33141620
Submission & procedure
- Submission deadline
- 19 Dec 2021, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£204k
Award date
06 Jan 2022
Contract start
20 Dec 2021
Contract end
19 Dec 2023
Awarded to
VE